🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

313,52 USD

Máx. histórico

322,75

4 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-2,86%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,12%

Cierre anterior

307,02

Rango de hoy

309,46 – 317,76

Volumen hoy

195.564

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
33,04 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 8 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/08/1994 44,92 44,92 43,04 44,92 +0,00% 4,17% 3.046
25/08/1994 43,04 44,92 43,04 44,92 +0,00% 4,35% 1.202
24/08/1994 43,98 44,92 43,04 44,92 +9,09% 4,26% 11.809
23/08/1994 41,17 41,17 41,17 41,17 +0,00% 0,00% 27
22/08/1994 43,04 43,04 41,17 41,17 -2,22% 4,35% 53
19/08/1994 43,98 43,98 42,11 42,11 -4,26% 4,26% 187
18/08/1994 43,98 43,98 43,98 43,98 +0,00% 0,00% 0
17/08/1994 41,17 43,98 41,17 43,98 +2,17% 6,82% 240
16/08/1994 43,04 43,04 43,04 43,04 +0,00% 0,00% 0
15/08/1994 42,58 43,98 41,17 43,04 -2,13% 6,59% 668
12/08/1994 43,98 43,98 43,98 43,98 +4,44% 0,00% 267
11/08/1994 43,98 43,98 41,64 42,11 -4,26% 5,32% 8.549
10/08/1994 43,98 43,98 43,98 43,98 +0,00% 0,00% 267
09/08/1994 43,98 43,98 43,98 43,98 +0,00% 0,00% 53
08/08/1994 41,17 43,98 41,17 43,98 +2,17% 6,82% 1.630
05/08/1994 43,04 43,04 43,04 43,04 +4,55% 0,00% 80
04/08/1994 41,17 41,17 41,17 41,17 +2,33% 0,00% 240
03/08/1994 40,24 40,24 40,24 40,24 -2,27% 0,00% 240
02/08/1994 42,11 42,11 41,17 41,17 -4,35% 2,22% 5.878
01/08/1994 39,30 43,04 39,30 43,04 +6,98% 9,52% 908
29/07/1994 41,17 42,11 39,30 40,24 +2,38% 6,82% 3.206
28/07/1994 39,30 42,11 39,30 39,30 -4,55% 7,14% 4.008
27/07/1994 41,17 41,17 41,17 41,17 -4,35% 0,00% 1.576
26/07/1994 42,11 43,04 42,11 43,04 +4,55% 2,22% 3.233
25/07/1994 41,17 42,11 41,17 41,17 -6,38% 2,27% 294
22/07/1994 43,98 46,79 42,11 43,98 -6,00% 10,64% 2.885
21/07/1994 44,86 46,79 43,98 46,79 +6,38% 6,26% 267
20/07/1994 43,98 43,98 43,98 43,98 -6,00% 0,00% 481
19/07/1994 46,79 46,79 46,79 46,79 +2,04% 0,00% 27
18/07/1994 45,85 45,85 43,04 45,85 +6,52% 6,12% 4.969